参考文献/References:
［1］ BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2018,68(6):394-424.
［2］ RAWLA P,SUNKARA T,GADUPUTI V.Epidemiology of pancrea-tic cancer:global trends,etiology and risk factors［J］.World J Oncol,2019,10(1):10-27.
［3］ ZABOROWSKI M P,BALAJ L,BREAKEFIELD X O,et al.Extracellular vesicles:composition,biological relevance,and methods of study［J］.Bioscience,2015,65(8):783-797.
［4］ HEIJNEN H F,SCHIEL A E,FIJNHEER R,et al.Activated platelets release two types of membrane vesicles:microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules［J］.Blood,1999,94(11):3791-3799.
［5］ LOWRY M C,GALLAGHER W M,O′DRISCOLL L.The role of exosomes in breast cancer［J］.Clin Chem,2015,61(12):1457-1465.
［6］ YANG N,LI S,LI G,et al.The role of extracellular vesicles in mediating progression,metastasis and potential treatment of hepatocellular carcinoma［J］.Oncotarget,2017,8(2):3683-3695.
［7］ KALLURI R.The biology and function of exosomes in cancer［J］.J Clin Invest,2016,126(4):1208-1215.
［8］ MELO S A,LUECKE L B,KAHLERT C,et al.Glypican-1 identifies cancer exosomes and detects early pancreatic cancer［J］.Nature,2015,523(7559):177-182.
［9］ MELO S A,SUGIMOTO H,O′CONNELL J T,et al.Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis［J］.Cancer Cell,2014,26(5):707-721.
［10］ THRY C.Exosomes:secreted vesicles and intercellular communications［J］.F1000 Biol Rep.2011,3:15.
［11］ WHITESIDE T L.Exosomes and tumor-mediated immune suppression［J］.J Clin Invest,2016,126(4):1216-1223.
［12］ VAHIDIA F,DUIJF P H G,SAFARZADEH E,et al.Interactions between cancer stem cells,immune system and some environmental components:friends or foes［J］.Immunol Lett,2019,208:19-29.
［13］ RAUTELA J,DAGLEY L F,SCHUSTER I S,et al.Therapeutic blockade of activin-A improves NK cell function and antitumor immunity［J］.Sci Signal,2019,12(596):eaat7527.
［14］ MAMESSIER E,SYLVAIN A,THIBULT M L,et al.Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity［J］.J Clin Invest,2011,121(9):3609-3622.
［15］ PLATONOVA S,CHERFILS-VICINI J,DAMOTTE D,et al.Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma［J］.Cancer Res,2011,71(16):5412-5422.
［16］ ZHAO J,SCHLOBER H A,WANG Z,et al.Tumor-derived extracellular vesicles inhibit natural killer cell function in pancreatic cancer［J］.Cancers (Basel),2019,11(6):874.
［17］ SHEN T,HUANG Z,SHI C,et al.Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK-mediated endoplasmic reticulum stress［J］.FASEB J,2020,34(6):8442-8458.
［18］ LUNDEQUIST A,PEJLER G.Biological implications of preformed mast cell mediators［J］.Cell Mol Life Sci,2011,68(6):965-975.
［19］ MOON T C,BEFUS A D,KULKA M.Mast cell mediators:their differential release and the secretory pathways involved［J］.Front Immunol,2014,5:569.
［20］ KRYSTEL-WHITTEMORE M,DILEEPAN K N,WOOD J G.Mast cell:a multi-functional master cell［J］.Front Immunol,2016,6:620.
［21］ GORZACZANY Y,AKIVA E,KLEIN O,et al.Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor［J］.Cancer Lett,2017,397:23-32.
［22］ GORZALCZANY Y,MERIMSKY O,SAGI-EISENBERG R.Mast cells are directly activated by cancer cell-derived extracellular vesicles by a CD73- and adenosine-dependent mechanism［J］.Transl Oncol,2019,12(12):1549-1556.
［23］ WEI Q,WEI L,ZHANG J,et al.EphA2 enriched exosomes promote cell migration and are a potential diagnostic serum marker in pancreatic cancer［J］.Mol Med Rep,2020,22(4):2941-2947.
［24］ CHE S P Y,PARK J Y,STOKOL T.Tissue factor-expressing tumor-derived extracellular vesicles activate quiescent endothelial cells via protease-activated receptor-1［J］.Front Oncol,2017,7:261.
［25］ CHIBA M,KUBOTA S,SAKAI A,et al.Celltocell communication via extracellular vesicles among human pancreatic cancer cells derived from the same patient［J］.Mol Med Rep,2018,18(4):3989-3996.
［26］ LI M,ZHANG F,SU Y,et al.Nanoparticles designed to regulate tumor microenvironment for cancer therapy［J］.Life Sci,2018,201:37-44.
［27］ SHANG D,XIE C,HU J,et al.Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2［J］.J Cell Mol Med,2020,24(1):588-604.
［28］ PESSOLANO E,BELVEDERE R,BIZZARRO V,et al.Annexin A1 may induce pancreatic cancer progression as a key player of extracellular vesicles effects as evidenced in the in vitro MIA PaCa-2 model system［J］.Int J Mol Sci,2018,19(12):3878.
［29］ COSTA-SILVA B,AIELLO N M,OCEAN A J,et al.Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver［J］.Nat Cell Biol,2015,17(6):816-26.
［30］ YU S,LI Y,LIAO Z,et al.Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma［J］.Gut,2020,69(3):540-550.
［31］ LUCIEN F,LAC V,BILLADEAU D D,et al.Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases［J］.Oncotarget,2019,10(10):1045-1055.
［32］ SHIN H S,JUNG S B,PARK S,et al.ALPPL2 is a potential diagnostic biomarker for pancreatic cancer-derived extracellular vesicles［J］.Mol Ther Methods Clin Dev,2019,15:204-210.
［33］ LECA J,MARTINEZ S,LAC S,et al.Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness［J］.J Clin Invest,2016,126(11):4140-4156.
［34］ WEIZMAN N,KRELIN Y,SHABTAY-ORBACH A,et al.Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase［J］.Oncogene,2014,33(29):3812-3819.
［35］ RICHARDS K E,ZELENIAK A E,FISHEL M L,et al.Cancera-ssociated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells［J］.Oncogene,2017,36(13):1770-1778.
［36］ YANG Z,ZHAO N,CUI J,et al.Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210［J］.Cell Oncol (Dordr),2020,43(1):123-136.
［37］ FAN J,WEI Q,KOAY E J,et al.Chemoresistance transmission via exosome-mediated EphA2 transfer in pancreatic cancer［J］.Theranostics,2018,8(21):5986-5994.
［38］ KIMURA H,YAMAMOTO H,HARADA T,et al.CKAP4,a DKK1 receptor,is a biomarker in exosomes derived from pancreatic cancer and a molecular target for therapy［J］.Clin Cancer Res,2019,25(6):1936-1947.
［39］ YING H,KIMMELMAN A C,LYSSIOTIS C A,et al.Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism［J］.Cell,2012,149(3):656-670.
［40］ KAMERKAR S,LEBLEU V S,SUGIMOTO H,et al.Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer［J］.Nature,2017,546(7659):498-503.
相似文献/References:
[1]李 丽,赵江海.立体定向低分割适形放射治疗胰腺癌38 例临床观察与护理[J].新乡医学院学报,2006,23(06):626.
[2]刘宝军,周建华,包金英.替吉奥用于转移性胰腺癌治疗的研究进展[J].新乡医学院学报,2012,29(01):000.
[3]盖守娟.细胞周期蛋白依赖性激酶抑制因子2A基因表达与胰腺癌临床病理特征的关系[J].新乡医学院学报,2021,38(6):573.[doi:10.7683/xxyxyxb.2021.06.016]
GAI Shoujuan.Relationship between the expression of cyclin-dependent kinase inhibitor 2A gene and clinicopathological features of pancreatic cancer[J].Journal of Xinxiang Medical University,2021,38(9):573.[doi:10.7683/xxyxyxb.2021.06.016]
[4]郭瑞敏,曹毓琳,程世翔,等.间充质干细胞源性外泌体在呼吸系统疾病中的应用与机制研究进展[J].新乡医学院学报,2021,38(11):1084.[doi:10.7683/xxyxyxb.2021.11.017]
[5]熊慧敏,许小凡,段丽芳,等.白细胞介素-6在胰腺炎症和肿瘤中的作用机制研究进展[J].新乡医学院学报,2019,36(12):1191.[doi:10.7683/xxyxyxb.2019.12.022]
[6]田龙夫,崔云峰,张 琦,等.天然植物中生物碱类药物抗胰腺癌作用的研究进展[J].新乡医学院学报,2018,35(4):343.[doi:10.7683/xxyxyxb.2018.04.023]
N/A.N/A[J].Journal of Xinxiang Medical University,2018,35(9):343.[doi:10.7683/xxyxyxb.2018.04.023]
[7]贾如江,侯丽艳,尹清臣,等.轴突诱导因子4D和血管内皮生长因子在胰腺癌组织中的表达[J].新乡医学院学报,2016,33(11):950.[doi:10.7683/xxyxyxb.2016.11.004]
JIA Ru-jiang,HOU Li-yan,YIN Qing-chen,et al.Clinical significance of the expression of semaphorin 4D and vascular endothelial growth factor in pancreatic carcinoma[J].Journal of Xinxiang Medical University,2016,33(9):950.[doi:10.7683/xxyxyxb.2016.11.004]